“…Among the patients with mutations that could not be transferred to sulfonylurea, the L164P mutation of KCNJ11 has been previously reported as a sulfonylurea resistant mutation . On the contrary, V59A in patient 15 (Table ) has been reported as a mutation that could be transferred to sulfonylurea . Our patient, however, could not be switched to glibenclamide, even at the dosage of 2 mg/kg/d.…”